drugset / Trial / NCT04081324
A Study of Lasmiditan in Healthy Chinese Participants
RandomizedParallel-groupDouble-blindBasic science
Summary
This is a study of lasmiditan in healthy Chinese participants. The purposes are: * To evaluate the safety of lasmiditan * To learn more about how the body processes lasmiditan The study will last up to 50 days for each participant.
Timeline
- Start
- 2019-11-13
- Primary completion
- 2020-06-15
- Completion
- 2020-06-15
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Lasmiditan | Small molecule | 50 mg | Oral |
| Subject | Lasmiditan | Small molecule | 100 mg | Oral |
| Subject | Lasmiditan | Small molecule | 200 mg | Oral |
Indications
No indication recorded.